Arrowhead Pharmaceuticals, Inc. (ARWR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$57.07
Day's range
$60.97

Arrowhead Pharmaceuticals Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 14.83 M $1.21 B   -18.34% 10.41%
AVORO CAPITAL ADVISORS LLC 08/14/2026 11.36 M $925.59 M   6.13% 7.97%
FMR LLC 08/13/2026 8.04 M $655.32 M   10.64% 5.65%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 6.35 M $517.70 M   -11.12% 4.46%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 6.11 M $498.10 M   1.30% 4.29%
STATE STREET CORP 08/07/2026 5.69 M $464.17 M   -12.34% 4.00%
NORGES BANK 08/12/2026 3.90 M $317.61 M   100.00% 2.74%
INVESCO LTD. 08/14/2026 3.88 M $316.58 M   18.39% 2.73%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 3.53 M $298.81 M   -17.49% 2.48%
FRED ALGER MANAGEMENT, LLC 08/14/2026 3.30 M $269.14 M   -1.21% 2.32%
BAKER BROS. ADVISORS LP 08/14/2026 1.99 M $162.43 M   0.00% 1.40%
SIREN, L.L.C. 08/13/2026 1.72 M $139.83 M   6.19% 1.20%
VESTAL POINT CAPITAL, LP 08/14/2026 1.58 M $128.38 M   -30.77% 1.11%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 08/14/2026 1.39 M $113.22 M   -11.71% 0.98%
FIRST TRUST ADVISORS LP 08/11/2026 1.35 M $110.28 M   807.10% 0.95%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 1.35 M $110.08 M   13.46% 0.95%
JUPITER TOPCO LLC 08/14/2026 1.22 M $99.62 M   100.00% 0.86%
NORTHERN TRUST CORP 08/13/2026 1.19 M $97.23 M   -27.96% 0.84%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 1.18 M $96.31 M   94.17% 0.83%
GOLDMAN SACHS GROUP INC 08/14/2026 1.15 M $93.74 M   -33.90% 0.81%
BANK OF AMERICA CORP /DE/ 08/14/2026 1.14 M $92.91 M   7.08% 0.80%
HOOD RIVER CAPITAL MANAGEMENT LLC 08/14/2026 1.12 M $91.35 M   6.08% 0.79%
HOLOCENE ADVISORS, LP 08/14/2026 1.11 M $90.16 M   100.00% 0.78%
MORGAN STANLEY 08/13/2026 1.08 M $88.43 M   12.94% 0.76%
UBS ASSET MANAGEMENT AMERICAS INC 08/13/2026 964.48 K $78.61 M   -27.54% 0.68%
FISHER ASSET MANAGEMENT, LLC 08/04/2026 957.69 K $78.06 M   -14.00% 0.67%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 923.93 K $75.31 M   -22.49% 0.65%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 923.93 K $75.31 M   100.00% 0.65%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 896.74 K $73.09 M   -7.15% 0.63%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 867.60 K $70.72 M   -7.20% 0.61%
UBS GROUP AG 08/13/2026 861.52 K $70.22 M   -35.53% 0.60%
BANK OF NEW YORK MELLON CORP 08/06/2026 859.54 K $70.06 M   -10.48% 0.60%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 853.36 K $69.56 M   -18.24% 0.60%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 08/14/2026 830.25 K $67.67 M   53.71% 0.58%
WESTERN FINANCIAL CORP/CA 07/22/2026 820.24 K $66.86 M   0.00% 0.58%
JPMORGAN CHASE & CO 08/12/2026 637.40 K $51.77 M   -6.69% 0.45%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 625.57 K $50.99 M   -25.26% 0.44%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 596.57 K $48.63 M   57.48% 0.42%
TWO SIGMA INVESTMENTS, LP 08/14/2026 580.61 K $47.33 M   1,521.81% 0.41%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 573.42 K $46.71 M   -54.96% 0.40%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 558.64 K $45.53 M   -14.13% 0.39%
LORD, ABBETT & CO. LLC 08/14/2026 540.47 K $44.05 M   72.77% 0.38%
1832 ASSET MANAGEMENT L.P. 08/13/2026 538.50 K $43.89 M   100.00% 0.38%
PRINCIPAL FINANCIAL GROUP INC 08/04/2026 514.66 K $41.95 M   5.01% 0.36%
HRT FINANCIAL LP 08/14/2026 498.66 K $40.65 M   100.00% 0.35%
VOYA INVESTMENT MANAGEMENT LLC 08/12/2026 483.50 K $39.41 M   -26.31% 0.34%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 470.75 K $38.37 M   128.07% 0.33%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 468.92 K $38.22 M   -54.76% 0.33%
FRANKLIN RESOURCES INC 08/13/2026 462.13 K $37.67 M   -0.12% 0.32%
D. E. SHAW & CO., INC. 08/14/2026 431.56 K $35.18 M   -63.55% 0.30%

Arrowhead Pharmaceuticals Inc. institutional Ownership - FAQ's

During the previous two years, 662 institutional investors and hedge funds held shares of Arrowhead Pharmaceuticals Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 14.83 M

Avoro Capital Advisors LLC: 11.36 M

FMR LLC: 8.04 M

VANGUARD PORTFOLIO MANAGEMENT LLC: 6.35 M

VANGUARD CAPITAL MANAGEMENT LLC: 6.11 M

STATE STREET CORP: 5.69 M

84.30% of Arrowhead Pharmaceuticals Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 174.70 M shares in the last 24 months. This purchase volume represents approximately $10.60 B in transactions.